2006
DOI: 10.1080/03639040500529093
|View full text |Cite
|
Sign up to set email alerts
|

Development and Preliminary Experience with an Ease of Extractability Rating System for Prescription Opioids

Abstract: One important factor in the abuse potential of an opioid product is the ease with which active drug can be extracted. There are currently no standards for testing or reporting extractability. This article describes the development of an Extractability Rating System for use by the pharmaceutical industry and regulators. Despite several limitations, this effort serves as a call for standardized testing and reporting so that products can be accurately rated, and should help establish goals for drug developers who… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(12 citation statements)
references
References 9 publications
0
12
0
Order By: Relevance
“…To this end, abusers have developed both simple and sophisticated tampering methods specific to each drug product to achieve a better high. Examples of tampering methods include (i) separating the opioid compound from excipients and undesirable active ingredients; (ii) overcoming ER formulations (beads, layers, matrices); (iii) removing the opioid compound from high-dose formulations (patches, pills); and (iv) altering dosage forms for alternate routes of administration (2,3).…”
Section: Introductionmentioning
confidence: 99%
“…To this end, abusers have developed both simple and sophisticated tampering methods specific to each drug product to achieve a better high. Examples of tampering methods include (i) separating the opioid compound from excipients and undesirable active ingredients; (ii) overcoming ER formulations (beads, layers, matrices); (iii) removing the opioid compound from high-dose formulations (patches, pills); and (iv) altering dosage forms for alternate routes of administration (2,3).…”
Section: Introductionmentioning
confidence: 99%
“…In addition, extractability studies are needed to determine how easily this formulation can be modified for misuse or abuse. 48 Another added-ingredient approach is the use of the vitamin niacin, which is designed to induce unpleasant, but temporary, symptoms if too many tablets are consumed. 44 The efficacy of agonist-antagonist and agonist-additional active ingredient formulations in reducing misuse and abuse of opioids in the real world is still untested.…”
Section: Pharmacological Strategiesmentioning
confidence: 99%
“…Some authors attempted to standardize the evaluation of extractability of active principles from pharmaceutics presentations [59]. These authors referred to opioids, but these studies were based on an interesting method.…”
Section: Discussionmentioning
confidence: 99%